Commentary: Over-diagnosis in breast cancer screening

British Medical Journal

Volumn 332, Issue 7543, 2006, Pages 691-692

  Møller, Henrik ^a   Davies, Elizabeth ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RESEARCH; CANCER RISK; CANCER SCREENING; FOLLOW UP; HUMAN; LIFE EXPECTANCY; MAMMOGRAPHY; NOTE; PRIORITY JOURNAL; AGED; BREAST TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC ERROR; FEMALE; MASS SCREENING; MIDDLE AGED; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; STANDARD; STATISTICS; SWEDEN;

AGED; BREAST NEOPLASMS; DIAGNOSTIC ERRORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; SWEDEN;

EID: 33645505994     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.38768.401030.7C     Document Type: Note

References (4)

1. Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP. Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. BMJ 2006;332:689-91.
2. International Agency for Research on Cancer. IARC handbooks of cancer prevention. Breast cancer screening. Lyon, France: IARC Press, 2002.
3. Duffy SW Some current issues in breast cancer screening. J Med Screen 2005;12:128-33.
4. Moller B, Weedon-Fekjaer H, Hakulinen T, Tryggvadottir L, Storm HH, Talback M, et al. The influence of mammographic screening on national trends in breast cancer incidence. Eur J Cancer Prev 2005;14:117-28.